Upload
kylie-madden
View
218
Download
3
Tags:
Embed Size (px)
Citation preview
HIV/AIDS situation in Serbia
GORDANA J. DRAGOVIĆ LUKIĆ, MD, PhDDepartment of Clinical Pharmacology, Pharmacology and Toxicology;
School of Medicine, University of Belgrade, Belgrade, Serbia
IT
BiH
MN
HR
HRO
BG
MK
AL
GRTR
SLO
SERBIA
A
Belgrade, Serbia
Current Epidemiological HIV/AIDSSituation in Serbia
■ HIV prevalence (case registration by the end of June 2010.):
2414 cumulative
1472 AIDS
962 died
1382 PLWHA
■ HIV testing prevalence very low: 1.5/1000
(6 -11x higher numbers - “real life”)
■ Since 1987 mandatory HIV testing
Current Epidemiological HIV/AIDSSituation in Serbia
■ Of all HIV/AIDS
cases in 2010:
47% IDUs
62% MSM
31% heterosexual
■ HAART introduced
by the public health
insurance system in 1997.
Currently available antiretroviral drug in Serbia ■ NRTI
AZT, ZDV Zidosan®
ddI Videx EC®
ddI Videx EC®
d4T Zerit®
d4T Zerit®
3TC Epivir®
ABC Ziagen®
3TC/ZDV Combivir®
TDF/FTC Truvada®
ABC/3TC Kivexa®
■ NNRTI
EFV Stocrin®
NVP Viramune®
ETV Intelence®
Currently available antiretroviral drug in Serbia
■ PI
LPV/r Aluvia®
IDV Crixivan®
RTV Norvir®
SQV Invirase®
FPV Telzir®
DRV Prezista®
■ II
RLG Isentress®
■ R5
MVC Celsentri®
■ IF
T-20 Fuzeon®
Beograd
HIV/AIDS Centers in Serbia
■ Beograd (890 pts)
■ Novi Sad (76 pts)
■ Nis (54 pts)
■ Kragujevac (4 pts)
Novi Sad
Nis
Kragujevac
Previous responses to HIV/AIDS Challenge
■ 2002 National Commission to fight
HIV/AIDS
■ 2005-2010 National Strategy for the
fight against HIV/AIDS in Serbia
■ 2006 National Office for HIV/AIDS
■ 2010-2015 National Strategy for the
fight against HIV/AIDS in Serbia
Main achievements in the
last few years:
Previous responses to HIV/AIDS Challenge
Main achievements in the
last few years:
■ 2007 National Guideline for
Clinical Management and
Treatment of HIV Infection
■ 2008 Candle light memorial day
■ 2009 Antidiscrimination law
■ May 2009 New EACS
Guidelines version addopted as
a National Guidelines
2008 Candle light memorial day